Endoscopic Lung Volume Reduction with Valves Improves Cardiovascular Adaptability and 6-MWT Performance in Severely Limited COPD Patients
Lara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno · 2026
Read Endoscopic Lung Volume Reduction with Valves Improves Cardiovascular Adaptability and 6-MWT Performance in Severely Limited COPD Patients by Lara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13286814.txt.
Description
Lara Farber and colleagues revisit who benefits most from lung valve treatment in severe emphysema in a 2026 retrospective study. One-way valves deflate the worst lung lobe, yet patients who can barely walk were long excluded from trials as too risky. Records of 54 Berlin patients were split at a six-minute walking distance of 140 meters, comparing lung function, quality of life, and walk-test details after treatment.
Both groups gained lung function and quality of life to a similar degree. The frailest walkers, though, added far more distance than the stronger group, a mean gain past one hundred meters against roughly a dozen. Their heart rates also settled further from baseline to follow-up, hinting at a cardiovascular dividend, while oxygen levels changed alike. The authors argue the lowest walkers should not be turned away.
Catalog record
| CREATOR | Lara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46177 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |